FTY-720

被引：5
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2002年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
FTY-720 (Mitsubishi Pharma, Taito, Novartis) is a novel immunosuppressant which is currently undergoing phase II trials for organ transplantation. The compound represents a novel concept in immunosuppression, protecting the transplant against T-cells without affecting the host's ability to respond to antigens.
引用
收藏
页码：501 / 506
页数：6
相关论文
共 50 条
  • [11] Pretreatment with FTY-720 protects renal allografts against preservation-reperfusion injury.
    Dragun, D
    Böhler, T
    Waiser, J
    Neumayer, HH
    Luft, F
    Budde, K
    Haller, H
    TRANSPLANTATION, 2000, 69 (08) : S127 - S127
  • [12] Fingolimod (FTY-720) is Capable of Reversing Tumor Necrosis Factor Induced Decreases in Cochlear Blood Flow
    Bertlich, Mattis
    Ihler, Friedrich
    Weiss, Bernhard G.
    Freytag, Saskia
    Jakob, Mark
    Strupp, Michael
    Pellkofer, Hannah
    Canis, Martin
    OTOLOGY & NEUROTOLOGY, 2017, 38 (08) : 1213 - 1216
  • [13] Effect of FTY-720 on Pulmonary Fibrosis in Mice via the TGF-β1 Signaling Pathway and Autophagy
    Jin, Yuying
    Liu, Weidong
    Gao, Ge
    Song, Yilan
    Liu, Hanye
    Li, Liangchang
    Zhou, Jiaxu
    Yan, Guanghai
    Cui, Hong
    BIOMOLECULES & THERAPEUTICS, 2023, 31 (04) : 434 - 445
  • [14] Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720
    Camp, Sara M.
    Chiang, Eddie T.
    Sun, Chaode
    Usatyuk, Peter V.
    Bittman, Robert
    Natarajan, Viswanathan
    Garcia, Joe G. N.
    Dudek, Steven M.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2016, 194 : 85 - 93
  • [15] Immunomodulatory Drug Fingolimod (FTY-720) Inhibits Distal T Cell Receptor (TCR) Signaling in Human T Cells
    Baer, Alan
    MOLECULAR THERAPY, 2017, 25 (05) : 184 - 184
  • [16] FTY 720.
    不详
    Drugs in R & D, 1999, 1 (1) : 78 - 80
  • [17] FTY720-derivatives do not induce FTY720-like lymphopenia
    Segura-Ulate, Ismael
    Belcher, Troy K.
    Vidal-Martinez, Guadalupe
    Vargas-Medrano, Javier
    Perez, Ruth G.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : 187 - 189
  • [18] Pharmacodynamics of FTY 720 in rats
    Chiba, K
    Nakayama, S
    Arima, N
    Kawai, R
    TRANSPLANTATION, 1999, 67 (07) : S62 - S62
  • [19] Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720 (vol 191, pg 16, 2015)
    Camp, Sara M.
    Chiang, Eddie T.
    Sun, Chaode
    Usatyuk, Peter V.
    Bittman, Robert
    Natarajan, Viswanathan
    Garcia, Joe G. N.
    Dudek, Steven M.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2015, 191 : 17 - 17
  • [20] Treatment with FTY-720 reverses social recognition deficits without affecting clinical scores or impaired motor performance in EAE in SJL mice
    De Bruin, Natasja M. W. J.
    Schmitz, Katja
    Tegeder, Irmgard
    Talmon, Sonja
    Jordan, Holger
    Schmidt, Mike
    Haeussler, Annett
    Geisslinger, Gerd
    Parnham, Michael J.
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 115 - 115
12345